CRISPR Therapeutics to Present at Annual Healthcare Conference

Got story updates? Submit your updates here. ›

CRISPR Therapeutics, a leading biopharmaceutical company focused on developing transformative gene-based medicines, announced that members of its senior management team will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13th at 2:15 p.m. ET. The company, which recently achieved a historic milestone with the approval of the world's first CRISPR-based therapy, will provide an update on its broad and diversified pipeline across various therapeutic areas.

Why it matters

CRISPR Therapeutics is at the forefront of the gene-editing revolution, with its pioneering CRISPR-based therapies offering new hope for patients with serious genetic diseases. The company's presentation at this prestigious healthcare conference will showcase its advancements and provide investors and the broader industry with insights into its strategic direction.

The details

The live webcast of CRISPR Therapeutics' fireside chat will be available on the company's website, and a replay will be archived for 14 days following the presentation. CRISPR Therapeutics has evolved from a research-stage organization into an industry leader, marking a historic milestone with the approval of CASGEVY® (exagamglogene autotemcel [exa-cel]), the world's first CRISPR-based therapy, for eligible patients with sickle cell disease and transfusion-dependent beta thalassemia.

• The presentation will take place on Monday, April 13, 2026 at 2:15 p.m. ET.

What’s next

Investors and the public will be able to access the live webcast of the presentation on CRISPR Therapeutics' website, and a replay will be available for 14 days following the event.